You have 9 free searches left this month | for more free features.

Fairfax (1)

Houston (1)

Minneapolis (1)

Blood Cancer (1)

Multiple Myeloma (1)

NHL (1)

Refractory Multiple Myeloma (1)

Refractory Non-Hodgkin Lymphoma (1)

Relapsed Multiple Myeloma (1)

Relapsed Non-Hodgkin Lymphoma (1)

Recruiting (1)

phase 1/phase 2 (1)

Indapta Therapeutics, INC. (1)

cyclophosphamide (1)

daratumumab (1)

fludarabine (1)

idp-023 (1)

interleukin-2 (1)

mesna (1)

rituximab (1)

drug (1)

Industry (1)

Interventional (1)

idp-023

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Nov 7, 2023